SG StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CMS

2.100

-0.050-2.33%

Volume:3.90K

Turnover:8.19K

Market Cap:5.12B

PE:17.30

High:2.100

Open:2.100

Low:2.100

Close:2.150

52wk High:2.550

52wk Low:2.024

Shares:2.44B

Float Shares:1.17B

Volume Ratio:2.83

T/O Rate:0.00%

Dividend:0.05

Dividend Rate:2.41%

EPS(TTM):0.121

EPS(LYR):0.667

ROE:9.91%

ROA:5.58%

PB:1.62

PE(LYR):3.15

Loading ...

Overview Company News Filings

China Medical System Gets China Nod to Market Renal Anaemia Drug

China Medical System says China approves Desidustat Tablets for renal anaemia

China Medical System Gains NMPA Nod to Begin Trials of INHBE-Targeting Obesity Drug

China Medical System to Review 2025 Results at Mar, 16 2026 Board Meeting

China Medical System reports stable share capital for Feb 2026

China Medical System’s Dermavon Gets Priority Review for Ruxolitinib Cream in China

China Medical System Signs Exclusive Distribution Deal for Lidoderm in Mainland China

Insilico Medicine Enters Drug Development Partnership With China Medical System

MT Newswires Live

China Medical System wins NMPA green light for Phase I study of complement factor B inhibitor CMS-D017

China Medical System Reports No Share Capital Changes for Jan, 31 2026

China Medical System's Drug Granted Clinical Trials Approval; Shares Up Nearly 7%

China Medical System Gains NMPA Clearance to Begin Clinical Trials for PNH Drug

China Medical System Gets NMPA Nod for Nation’s First Targeted Vitiligo Therapy

SGX Weekly Review | STI Rises 1.9%; Comba Soars 22%; CMS, CityDev Rise 11%; Nio Drops 12%; YZJ Maritime Falls 8%

China Medical System Reports Stable Share Capital for Dec, 31 2025

China Medical System’s NDA for Innovative Stroke Drug Y-3 Accepted by China’s NMPA

China Medical System Reports Unchanged Share Capital for Nov 2025

SGX Weekly Review | STI up 1.44%; Sheng Siong Soars 10%; Singtel Rises 9%; POP MART HK SDR Falls 8%

China Medical System Holdings files October 2025 monthly return with no share changes

China Medical System’s MG-K10 New Drug Application for Atopic Dermatitis Accepted by NMPA

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/8A8.SI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"8A8.SI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"8A8.SI\",,,,,undefined,":{"symbol":"8A8.SI","market":"SI","secType":"STK","nameCN":"CMS","latestPrice":2.1,"timestamp":1773393360000,"preClose":2.15,"halted":0,"volume":3900,"delay":15,"changeRate":-0.023255813953488292,"nameEN":"CMS","floatShares":1174455088,"shares":2439528512,"eps":0.121358,"marketStatus":"Market Closed","change":-0.05,"latestTime":"03-13 17:16:00 SGT Delay","open":2.1,"high":2.1,"low":2.1,"amount":8190,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.121358,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1773621000000},"marketStatusCode":7,"adr":0,"exchange":"SGX","adjPreClose":2.15,"openAndCloseTimeList":[[1773361800000,1773374400000],[1773378000000,1773393360000]],"volumeRatio":2.826087329237604,"lotSize":100,"tradeCurrency":"SGD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"8A8.SI\",,,,,undefined,":{"symbol":"8A8.SI","floatShares":1174455088,"roa":"5.58%","roe":"9.91%","lyrEps":0.667298,"volumeRatio":2.826087329237604,"shares":2439528512,"dividePrice":0.050649,"high":2.1,"amplitude":0,"preClose":2.15,"low":2.1,"week52Low":2.0235,"pbRate":"1.62","psRate":"3.51","week52High":2.55,"institutionHeld":0,"latestPrice":2.1,"eps":0.121358,"divideRate":0.024119,"volume":3900,"delay":15,"ttmEps":0.121358,"open":2.1,"prevYearClose":2.17,"prevWeekClose":2.14,"prevMonthClose":2.33,"prevQuarterClose":2.17,"fiveDayClose":2.14,"twentyDayClose":2.41,"sixtyDayClose":2.19},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/8A8.SI\",params:#limit:5,,,undefined,":[{"date":"2025-09-01","symbol":"8A8.SI","amount":0.028,"announcedDate":"2025-08-18","type":"dividend","lastAmount":null,"market":"SI","newRecordDate":"2025-09-02","defaultRemindTime":1756686600000,"name":"康哲药业控股有限公司","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-09","payableDate":"2025-09-02","currency":"SGD","dateTimestamp":1756656000000,"payDate":"2025-09-09"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"8A8.SI\",market:\"SI\",,,undefined,":[{"executeDate":"2025-09-01","recordDate":"2025-09-02","paymentDate":"2025-09-09","value":0.028,"currency":"SGD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"8A8.SI\",market:\"SI\",delay:true,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/sistock/value_analysis/stock/8A8.SI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:true,algorithm:1,,,undefined,":{"brief":{"id":"8A8.SI","date":"2026-03-13","current":17.304174,"percent":0,"low":16.330497,"twenty":17.618882,"median":18.19358,"eighty":18.884607,"high":20.673017,"avg":18.268701,"sd":0.873535,"marketCap":5015371308.59},"quantilePoints":[{"date":"2025-07-04","current":16.673233,"twenty":16.637771,"median":16.673233,"eighty":16.784911,"marketCap":4801375771.38},{"date":"2025-07-11","current":16.744588,"twenty":16.632861,"median":16.70891,"eighty":16.879396,"marketCap":4841392088.83},{"date":"2025-07-18","current":18.258819,"twenty":16.665869,"median":16.892752,"eighty":17.828992,"marketCap":5297909062.31},{"date":"2025-07-25","current":18.19266,"twenty":16.701775,"median":17.229904,"eighty":18.087702,"marketCap":5258845533.59},{"date":"2025-08-01","current":17.785876,"twenty":16.790498,"median":17.785876,"eighty":18.220583,"marketCap":5193558280},{"date":"2025-08-08","current":18.150915,"twenty":16.872719,"median":17.805225,"eighty":18.176448,"marketCap":5262086251.37},{"date":"2025-08-15","current":18.451509,"twenty":16.968806,"median":17.831938,"eighty":18.250971,"marketCap":5348960478.83},{"date":"2025-08-22","current":18.083959,"twenty":17.088452,"median":18.014301,"eighty":18.321178,"marketCap":5355917194.89},{"date":"2025-08-29","current":17.515947,"twenty":17.203283,"median":18.0059,"eighty":18.295418,"marketCap":5202284389.9},{"date":"2025-09-05","current":18.297389,"twenty":17.37062,"median":18.053281,"eighty":18.347554,"marketCap":5455494449.44},{"date":"2025-09-12","current":20.673017,"twenty":17.435599,"median":18.090262,"eighty":18.481114,"marketCap":6142633632.13},{"date":"2025-09-19","current":20.111924,"twenty":17.587437,"median":18.172396,"eighty":18.751822,"marketCap":5983876679.79},{"date":"2025-09-26","current":19.117097,"twenty":17.698026,"median":18.239199,"eighty":19.233922,"marketCap":5722696420.78},{"date":"2025-10-03","current":18.897472,"twenty":17.710368,"median":18.286379,"eighty":19.170232,"marketCap":5653596695.57},{"date":"2025-10-10","current":18.670211,"twenty":17.742181,"median":18.297389,"eighty":19.029247,"marketCap":5619863993.02},{"date":"2025-10-17","current":17.624343,"twenty":17.710368,"median":18.295244,"eighty":18.892438,"marketCap":5283447365.59},{"date":"2025-10-24","current":17.577683,"twenty":17.700917,"median":18.2686,"eighty":18.884888,"marketCap":5291417608.97},{"date":"2025-10-31","current":17.993641,"twenty":17.700917,"median":18.239199,"eighty":18.884607,"marketCap":5433064089.25},{"date":"2025-11-07","current":18.836089,"twenty":17.703847,"median":18.2686,"eighty":18.884607,"marketCap":5699425049.61},{"date":"2025-11-14","current":18.769496,"twenty":17.708887,"median":18.296112,"eighty":18.884607,"marketCap":5672862889.44},{"date":"2025-11-21","current":17.521012,"twenty":17.708887,"median":18.295244,"eighty":18.884607,"marketCap":5316361173.93},{"date":"2025-11-28","current":17.724128,"twenty":17.703847,"median":18.258819,"eighty":18.878239,"marketCap":5358338933.6},{"date":"2025-12-05","current":17.919868,"twenty":17.703847,"median":18.247211,"eighty":18.853034,"marketCap":5417961084.21},{"date":"2025-12-12","current":18.019573,"twenty":17.703847,"median":18.228444,"eighty":18.832294,"marketCap":5441881882.83},{"date":"2025-12-19","current":17.606268,"twenty":17.700917,"median":18.191843,"eighty":18.80759,"marketCap":5320959405.59},{"date":"2025-12-26","current":17.243491,"twenty":17.683107,"median":18.163857,"eighty":18.77902,"marketCap":5209534754.39},{"date":"2026-01-02","current":17.246004,"twenty":17.613017,"median":18.152131,"eighty":18.768222,"marketCap":5234627271.64},{"date":"2026-01-09","current":18.633486,"twenty":17.621613,"median":18.153083,"eighty":18.762743,"marketCap":5660420378.33},{"date":"2026-01-16","current":18.337696,"twenty":17.644918,"median":18.191026,"eighty":18.757043,"marketCap":5596371980.56},{"date":"2026-01-23","current":17.975631,"twenty":17.676989,"median":18.153083,"eighty":18.746879,"marketCap":5452513661.95},{"date":"2026-01-30","current":18.284809,"twenty":17.692494,"median":18.154035,"eighty":18.740548,"marketCap":5499431597.1},{"date":"2026-02-06","current":19.811509,"twenty":17.698099,"median":18.182156,"eighty":18.768222,"marketCap":6002389652.07},{"date":"2026-02-13","current":19.556185,"twenty":17.701986,"median":18.19358,"eighty":18.844561,"marketCap":5904343765.22},{"date":"2026-02-20","current":19.597337,"twenty":17.703847,"median":18.220007,"eighty":18.884607,"marketCap":5939248637.99},{"date":"2026-02-27","current":18.693346,"twenty":17.708887,"median":18.255223,"eighty":18.893343,"marketCap":5702017702.28},{"date":"2026-03-06","current":17.038189,"twenty":17.695815,"median":18.232858,"eighty":18.884888,"marketCap":5229249378.89},{"date":"2026-03-13","current":16.330497,"twenty":17.618882,"median":18.19358,"eighty":18.884607,"marketCap":5015371308.59}],"updateTime":1773515729331},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"8A8.SI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2619192249","title":"China Medical System Gets China Nod to Market Renal Anaemia Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2619192249","media":"MT Newswires","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619192249?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:35","pubTimestamp":1773405323,"startTime":"0","endTime":"0","summary":"China Medical System (HKG:0867, SGX:8A8) obtained marketing approval for renal anaemia drug Desidustat Tablets from China's National Medical Products Administration,The product is used for treating anaemia in non-dialysis adult patients with chronic kidney disease.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","SG9999015945.SGD","SG9999004220.SGD","SG9999015986.USD","IE00BVYPNQ40.USD","8A8.SI","LU2488822045.USD","00867","SG9999015952.SGD","SG9999015978.USD","IE00BMCWC346.EUR","BK6079","IE00BVYPNP33.GBP","BK1191","IE00BYV24P56.USD","IE00BGHQDM52.EUR"],"gpt_icon":0},{"id":"1197623254","title":"China Medical System says China approves Desidustat Tablets for renal anaemia","url":"https://stock-news.laohu8.com/highlight/detail?id=1197623254","media":"SGX Filings","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197623254?lang=en_us&edition=fundamental","pubTime":"2026-03-13 19:09","pubTimestamp":1773400142,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited announced on Mar, 13 2026 that China’s National Medical Products Administration approved Desidustat Tablets, an oral hypoxia-inducible factor-prolyl hydroxylase...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"China Medical System says China approves Desidustat Tablets for renal anaemia","news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["8A8.SI"],"gpt_icon":0},{"id":"1150008716","title":"China Medical System Gains NMPA Nod to Begin Trials of INHBE-Targeting Obesity Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1150008716","media":"SGX Filings","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150008716?lang=en_us&edition=fundamental","pubTime":"2026-03-04 20:17","pubTimestamp":1772626665,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited announced that on Mar, 4 2026 China’s National Medical Products Administration approved the company’s application to start clinical trials of CMS-D008, a...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"China Medical System Gains NMPA Nod to Begin Trials of INHBE-Targeting Obesity Drug","news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["8A8.SI"],"gpt_icon":0},{"id":"1104414314","title":"China Medical System to Review 2025 Results at Mar, 16 2026 Board Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1104414314","media":"SGX Filings","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104414314?lang=en_us&edition=fundamental","pubTime":"2026-03-04 19:17","pubTimestamp":1772623034,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited announced that its board will convene on Mar, 16 2026 to consider and approve the group’s annual results for the financial year ended Dec, 31 2025 and to deliberate on a potential final dividend. The notice was issued on Mar, 4 2026.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"China Medical System to Review 2025 Results at Mar, 16 2026 Board Meeting","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["8A8.SI"],"gpt_icon":0},{"id":"1128413900","title":"China Medical System reports stable share capital for Feb 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1128413900","media":"SGX Filings","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128413900?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:17","pubTimestamp":1772450275,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited said in a filing on Mar, 02 2026 that its authorised share capital remained unchanged at 20 billion ordinary shares, carrying a total par value of about 135...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"China Medical System reports stable share capital for Feb 2026","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["8A8.SI"],"gpt_icon":0},{"id":"1169948232","title":"China Medical System’s Dermavon Gets Priority Review for Ruxolitinib Cream in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1169948232","media":"SGX Filings","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169948232?lang=en_us&edition=fundamental","pubTime":"2026-02-24 18:05","pubTimestamp":1771927553,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited said on Feb, 24 2026 that its subsidiary Dermavon Holdings Limited has received National Medical Products Administration acceptance and Priority Review status...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"China Medical System’s Dermavon Gets Priority Review for Ruxolitinib Cream in China","news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["8A8.SI"],"gpt_icon":0},{"id":"1187329277","title":"China Medical System Signs Exclusive Distribution Deal for Lidoderm in Mainland China","url":"https://stock-news.laohu8.com/highlight/detail?id=1187329277","media":"SGX Filings","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187329277?lang=en_us&edition=fundamental","pubTime":"2026-02-12 18:12","pubTimestamp":1770891158,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited announced on Feb, 12 2026 that it has entered into a ten-year exclusive distribution agreement with Teikoku Pharma USA, Inc. for Lidoderm 5% lidocaine cataplasms...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"China Medical System Signs Exclusive Distribution Deal for Lidoderm in Mainland China","news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["8A8.SI"],"gpt_icon":0},{"id":"2610693787","title":"Insilico Medicine Enters Drug Development Partnership With China Medical System","url":"https://stock-news.laohu8.com/highlight/detail?id=2610693787","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610693787?lang=en_us&edition=fundamental","pubTime":"2026-02-10 09:38","pubTimestamp":1770687485,"startTime":"0","endTime":"0","summary":"Insilico Medicine  said it entered a drug development partnership with China Medical System , according to a Hong Kong bourse filing Tuesday.Under the agreement, the two sides will collaborate to co-develop at least two drugs.Insilico Medicine is expected to receive R&D funding support of up to \"several tens of millions of HKD\" for each program.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["00867","IE00BVYPNP33.GBP","8A8.SI","IE00BYV24P56.USD","SG9999015952.SGD","IE00BMCWC346.EUR","BK1141","IE00BVYPNQ40.USD","BK1191","SG9999015986.USD","03696","BK6079","SG9999015978.USD","SG9999015945.SGD","BK1593","IE00BGHQDM52.EUR","SG9999004220.SGD","LU2488822045.USD"],"gpt_icon":0},{"id":"1121643347","title":"China Medical System wins NMPA green light for Phase I study of complement factor B inhibitor CMS-D017","url":"https://stock-news.laohu8.com/highlight/detail?id=1121643347","media":"SGX Filings","labels":["policyRegulatory","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121643347?lang=en_us&edition=fundamental","pubTime":"2026-02-03 22:09","pubTimestamp":1770127790,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited announced that on Feb, 03 2026 the National Medical Products Administration approved its application to conduct clinical trials in healthy participants for...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"China Medical System wins NMPA green light for Phase I study of complement factor B inhibitor CMS-D017","news_tag":"policyRegulatory,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["8A8.SI"],"gpt_icon":0},{"id":"1179664871","title":"China Medical System Reports No Share Capital Changes for Jan, 31 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1179664871","media":"SGX Filings","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179664871?lang=en_us&edition=fundamental","pubTime":"2026-02-02 19:09","pubTimestamp":1770030574,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited announced that its authorised share capital stayed at 20.0 billion ordinary shares for the month ended Jan, 31 2026. The company said its issued share count was...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"China Medical System Reports No Share Capital Changes for Jan, 31 2026","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["8A8.SI"],"gpt_icon":0},{"id":"2608305398","title":"China Medical System's Drug Granted Clinical Trials Approval; Shares Up Nearly 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608305398","media":"MT Newswires","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608305398?lang=en_us&edition=fundamental","pubTime":"2026-02-02 14:32","pubTimestamp":1770013920,"startTime":"0","endTime":"0","summary":"China Medical System's  drug, CMS-D017, secured a clinical trials approval in China by the National Medical Products Administration, according to a Friday filing with the Singapore Exchange.Shares of the medical solutions company surged nearly % in Monday trading.Following the approval, the company will commence clinical trials in China to evaluate the safety, efficacy and other characteristics of the drug.The trial is seen as crucial in the group's efforts to enhance its capabilities in nephrology.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6079","8A8.SI"],"gpt_icon":0},{"id":"1126756280","title":"China Medical System Gains NMPA Clearance to Begin Clinical Trials for PNH Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1126756280","media":"SGX Filings","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126756280?lang=en_us&edition=fundamental","pubTime":"2026-01-30 20:10","pubTimestamp":1769775021,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited said on Jan, 30 2026 that China’s National Medical Products Administration has approved the company to start Phase I trials of its self-developed oral drug...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"China Medical System Gains NMPA Clearance to Begin Clinical Trials for PNH Drug","news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["8A8.SI"],"gpt_icon":0},{"id":"1104302580","title":"China Medical System Gets NMPA Nod for Nation’s First Targeted Vitiligo Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1104302580","media":"SGX Filings","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104302580?lang=en_us&edition=fundamental","pubTime":"2026-01-30 13:08","pubTimestamp":1769749716,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited said on Jan, 30 2026 that its skin-health subsidiary Dermavon Holdings Limited has received National Medical Products Administration approval for ruxolitinib...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"China Medical System Gets NMPA Nod for Nation’s First Targeted Vitiligo Therapy","news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["8A8.SI"],"gpt_icon":0},{"id":"1178491215","title":"SGX Weekly Review | STI Rises 1.9%; Comba Soars 22%; CMS, CityDev Rise 11%; Nio Drops 12%; YZJ Maritime Falls 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1178491215","media":"TigerNews SG","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178491215?lang=en_us&edition=fundamental","pubTime":"2026-01-11 17:05","pubTimestamp":1768122357,"startTime":"0","endTime":"0","summary":"Singapore shares jumped this week, with the STI rising 1.9%.In terms of individual stocks, $Man Oriental USD(M04.SI)$, $Comba(STC.SI)$ rose 22%; $CMS(8A8.SI)$, $CityDev(C09.SI)$, $JMH USD(J36.SI)$...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"6c94192564e416a03f6a9b9f46aa2e98","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["M04.SI","558.SI","P7VU.SI","8YZ.SI","8A8.SI","NIO.SI","STC.SI","HMTD.SI","C09.SI","J36.SI"],"gpt_icon":0},{"id":"1105806422","title":"China Medical System Reports Stable Share Capital for Dec, 31 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1105806422","media":"SGX Filings","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105806422?lang=en_us&edition=fundamental","pubTime":"2025-12-31 15:07","pubTimestamp":1767164831,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited has filed its monthly return with Hong Kong Exchanges and Clearing Limited for the period ended Dec, 31 2025. The filing shows that authorised share capital...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"China Medical System Reports Stable Share Capital for Dec, 31 2025","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["8A8.SI"],"gpt_icon":0},{"id":"1130453645","title":"China Medical System’s NDA for Innovative Stroke Drug Y-3 Accepted by China’s NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1130453645","media":"SGX Filings","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130453645?lang=en_us&edition=fundamental","pubTime":"2025-12-11 20:08","pubTimestamp":1765454885,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited announced that, on Dec, 11 2025, the National Medical Products Administration in China accepted the New Drug Application for Y-3 for Injection (proposed generic...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"China Medical System’s NDA for Innovative Stroke Drug Y-3 Accepted by China’s NMPA","news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["8A8.SI"],"gpt_icon":0},{"id":"1167284721","title":"China Medical System Reports Unchanged Share Capital for Nov 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1167284721","media":"SGX Filings","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167284721?lang=en_us&edition=fundamental","pubTime":"2025-12-01 18:09","pubTimestamp":1764583759,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited announced its monthly return on movements in securities for the month ended Nov, 30 2025. The company’s authorised share capital remained at 20 billion ordinary...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"China Medical System Reports Unchanged Share Capital for Nov 2025","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["8A8.SI"],"gpt_icon":0},{"id":"1137471580","title":"SGX Weekly Review | STI up 1.44%; Sheng Siong Soars 10%; Singtel Rises 9%; POP MART HK SDR Falls 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1137471580","media":"TigerNews SG","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137471580?lang=en_us&edition=fundamental","pubTime":"2025-11-09 13:20","pubTimestamp":1762665617,"startTime":"0","endTime":"0","summary":"Singapore shares rose this week, with the STI up 1.44%.In terms of individual stocks, $Sheng Siong(OV8.SI)$ rose 10%, $Singtel(Z74.SI)$ rose 9%, $Singtel 10(Z77.SI)$ rose 8%; while $SiamCement TH...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ee7ffe230cc1f2eb863fd470ffa92344","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["Z77.SI","8A8.SI","F17.SI","Z25.SI","HPCD.SI","HPPD.SI","TSCD.SI","OV8.SI","TCPD.SI","Z74.SI"],"gpt_icon":1},{"id":"1103779716","title":"China Medical System Holdings files October 2025 monthly return with no share changes","url":"https://stock-news.laohu8.com/highlight/detail?id=1103779716","media":"SGX Filings","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103779716?lang=en_us&edition=fundamental","pubTime":"2025-10-31 21:27","pubTimestamp":1761917222,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited submitted its monthly return for the period ended Oct, 31 2025, indicating no changes in its authorised, registered or issued share capital during the month.\\n\\n...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"China Medical System Holdings files October 2025 monthly return with no share changes","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["8A8.SI"],"gpt_icon":0},{"id":"1160985437","title":"China Medical System’s MG-K10 New Drug Application for Atopic Dermatitis Accepted by NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1160985437","media":"SGX Filings","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160985437?lang=en_us&edition=fundamental","pubTime":"2025-10-30 22:05","pubTimestamp":1761833118,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited said that China’s National Medical Products Administration accepted the marketing authorisation application on Oct, 30 2025 for Comekibart Injection (MG-K10), a...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"China Medical System’s MG-K10 New Drug Application for Atopic Dermatitis Accepted by NMPA","news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["8A8.SI"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":30,"code":"91000000","status":"200"}]}}